Welcome to our dedicated page for Cadre Hldgs SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cadre Holdings, Inc. (NYSE: CDRE) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. As a Delaware corporation listed on the New York Stock Exchange under the symbol CDRE, Cadre submits current reports on Form 8‑K, annual and quarterly reports, and other documents that describe its operations in safety and survivability equipment for law enforcement, first responder, military and nuclear markets.
In its Form 8‑K filings, Cadre reports material events such as quarterly financial results, investor presentations and significant transactions. For example, the company has filed 8‑Ks to furnish earnings press releases and slide presentations, and to disclose a securities purchase agreement to acquire TYR Tactical, a manufacturer of tactical gear and equipment for military, law enforcement and government agencies worldwide. These filings also confirm details such as Cadre’s incorporation in Delaware and its CDRE listing on the New York Stock Exchange.
Through its SEC reports, Cadre discusses non‑GAAP financial measures including EBITDA, adjusted EBITDA and adjusted EBITDA margin, explaining how these metrics relate to its GAAP results. Filings may also describe contract awards, like blast exposure monitoring programs handled by its Med‑Eng subsidiary, and provide additional context on acquisitions in nuclear safety and tactical equipment.
On Stock Titan, investors can review Cadre’s SEC filings alongside AI‑powered summaries that clarify key points in lengthy documents. Real‑time updates from EDGAR help users track new 8‑Ks, 10‑Qs and 10‑Ks as they are filed, while insider and governance‑related disclosures can be used to analyze management decisions and capital allocation. This page is a resource for understanding how Cadre communicates its financial performance, strategic transactions and risk factors through its regulatory filings.
Cadre Holdings (CDRE) filed a Form 144 notice for the proposed sale of 1,343,941 common shares through broker Merrill Lynch on the NYSE, with an approximate sale date of 11/17/2025.
The shares listed have an aggregate market value of $56,566,477 based on the filing data. The filing reports that 40,663,844 shares of the issuer’s common stock are outstanding, providing context for the size of the potential sale.
The securities to be sold include shares acquired on 12/07/2021 via a liquidating distribution and shares acquired on 11/10/2025 upon the vesting and settlement of restricted stock units under the issuer’s 2021 Stock Incentive Plan.
Cadre Holdings, Inc. (CDRE)
After this transaction, the reporting person beneficially owned 78,719 shares of Cadre Holdings common stock. The shares were sold in multiple trades within a price range of $43.50 to $43.82 per share, and detailed trade-by-trade information is available upon request as noted in the footnote.
A shareholder of Cadre Holdings (CDRE)27,370 shares of common stock through a broker, with an indicated aggregate market value of 1,193,605. The shares are of a class that had 40,663,844 shares outstanding and the proposed sale is targeted around 11/13/2025 on the NYSE.
The securities to be sold were acquired from the issuer via several restricted stock unit (RSU) awards on 03/09/2024, 03/13/2024, 03/18/2024, and 03/13/2025, totaling multiple RSU grants. The filing also notes that Brad Williams has sold blocks of 4,132 shares of common stock on 09/23/2025, 10/14/2025, and 10/24/2025, for gross proceeds of 152,754, 165,150, and 177,546, respectively.
Cadre Holdings (CDRE): CEO and Chairman Warren B. Kanders reported the vesting and settlement of a previously granted restricted stock units award. On November 10, 2025, 2,000,000 restricted stock units vested and were converted into Common Stock. To cover tax obligations from this vesting, the issuer withheld 787,000 shares at $43.32 per share, leaving Kanders with 1,258,584 shares held directly.
Kanders also reports indirect holdings of 10,216,192 shares through Kanders SAF, LLC, 1,305,650 shares through the Warren B. Kanders Roth IRA, and 23,450 shares through the Allison Kanders Roth IRA. He is listed as Director, 10% Owner, and Officer (CEO and Chairman).
Cadre Holdings (CDRE) reported strong Q3 2025 growth. Net sales rose to $155.9 million from $109.4 million a year ago, lifting gross profit to $66.6 million from $40.0 million. Operating income increased to $18.7 million from $5.4 million, and net income improved to $10.9 million from $3.7 million, equal to diluted EPS of $0.27 versus $0.09. For the nine months, net sales reached $443.1 million (from $391.6 million) and diluted EPS was $0.79 (from $0.58).
The balance sheet expanded following M&A and credit facility draws. Total assets were $792.1 million (from $652.7 million) with cash and cash equivalents of $150.9 million. Long-term debt, net, was $295.0 million (from $211.8 million), reflecting the April draw of $97.5 million under the delayed draw term loan A‑1 to fund the Zircaloy acquisition, which had total consideration, net, of $89.6 million. Operating cash flow was $42.5 million (versus $8.1 million) year-to-date. The company declared quarterly dividends of $0.095 per share in each quarter of 2025 to date. Remaining performance obligations were $69.9 million as of September 30, 2025, with approximately 51% expected over the next twelve months.
Cadre Holdings (CDRE) filed an 8-K announcing it issued a press release with financial results for the quarter ended September 30, 2025. The release and an investor presentation were furnished as Exhibits 99.1 and 99.2.
The materials include non-GAAP measures such as EBITDA, adjusted EBITDA, adjusted EBITDA margin, and last twelve months adjusted EBITDA, with reconciliations to comparable GAAP metrics in the exhibits. The company noted it does not provide a reconciliation for full-year 2025 Adjusted EBITDA guidance due to forecasting limitations. The information under Item 2.02 is furnished, not filed. A conference call presentation is set for November 5, 2025.
Cadre Holdings announced a definitive agreement for subsidiary Safariland to acquire TYR Tactical and related entities for $145,000,000, composed of $130,000,000 in cash and $15,000,000 in Cadre common stock, including $14,000,000 in unregistered shares and $1,000,000 in restricted stock units for certain employees.
The Seller may receive up to $25,000,000 in earn-out payments tied to Net Revenue targets in 2026–2028, capped at $8,333,334 for the first year and $8,333,333 for each subsequent year, with payouts beginning at 50% of the cap at 90% of target and scaling linearly to 100% at target. Closing also requires a separate real estate acquisition in Peoria, Arizona for $30,000,000 ($20,000,000 cash and $10,000,000 in unregistered shares).
The deal is subject to HSR and other customary approvals and conditions. Closing is expected on the later of January 5, 2026 or the third business day after conditions are met. Cadre will file a Form S-3 within 60 days after closing to register the resale of the unregistered shares issued as consideration. If a party fails to close after conditions are satisfied, the breaching party owes $10,000,000 plus documented expenses, and Buyer may seek specific performance.
Cadre Holdings, Inc. furnished a slide presentation used during a conference call and webcast to discuss its entry into a definitive agreement to acquire TYR Tactical. The presentation is attached as Exhibit 99.1 to this report dated October 29, 2025.
The materials were provided under Item 7.01 (Regulation FD Disclosure), meaning they are furnished rather than filed and are not subject to Section 18 of the Exchange Act. The company also indicates it has no obligation to publicly update or revise the information in the presentation.
Cadre Holdings, Inc. (CDRE) reported an insider transaction on Form 4. The company’s President sold 4,132 shares of common stock at $43 on 10/24/2025.
Following the sale, the reporting person directly owns 106,089 shares. The filing notes the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025.
CDRE filed a Form 144 notice for a proposed sale of 4,132 common shares through UBS Financial Services, with an aggregate market value of $177,676.00. The filing lists an approximate sale date of 10/24/2025 on the NYSE.
The shares were acquired as RSUs on 03/18/2024 from the issuer. As context, 40,663,844 shares were outstanding. The filer, identified as Brad Williams, reported sales in the past three months of 4,132 shares on 09/23/2025 for $152,884.00 and 4,132 shares on 10/14/2025 for $165,280.00.